SCHEMBL14968997

SCHEMBL14968997

C=CCc1c(Cl)nc2nc(N)c(C(N)=O)cc2c1C

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EEF2K O00418 4/20 0.37
RCE1 Q9Y256 1/20 0.36
ALDH1A1 P00352 2/20 0.34
GAA P10253 3/20 0.34
HSD17B10 Q99714 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
EEF2 P13639 1/20 0.33
KDM4E B2RXH2 2/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
IKBKB O14920 1/20 0.33
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
POLB P06746 1/20 0.31
CYP3A4 P08684 1/20 0.31
CD38 P28907 1/20 0.31
BTK Q06187 2/20 0.31
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14969003 0.79 RCE1 (0.44) EEF2KRCE1ALDH1A1GAAHSD17B10
SCHEMBL14969053 0.72 EEF2K (0.41) EEF2KRCE1ALDH1A1GAAEEF2
SCHEMBL14966496 0.69 KDM4E (0.38) EEF2KRCE1ALDH1A1GAAEEF2
SCHEMBL14966299 0.69 RCE1 (0.44) EEF2KRCE1ALDH1A1GAAEEF2
SCHEMBL14968947 0.69 IKBKB (0.39) EEF2KRCE1ALDH1A1GAAEEF2
SCHEMBL14968935 0.67 EEF2K (0.46) EEF2KRCE1ALDH1A1GAAEEF2
SCHEMBL20298365 0.65 POLB (0.49) EEF2KRCE1ALDH1A1GAAKDM4E
SCHEMBL9287278 0.65 NPSR1 (0.51) ALDH1A1GAAHSD17B10NPSR1KDM4E
SCHEMBL14968912 0.64 RCE1 (0.38) EEF2KRCE1ALDH1A1GAANPSR1
SCHEMBL20321443 0.63 EEF2K (0.44) EEF2KRCE1ALDH1A1GAAEEF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013072882-A1 2 -AMINO- 1, 8 -NAPHTHYRIDINE-3 -CARBOXAMIDE DERIVATIVES AS ANTIMICROBIAL AGENTS ACTELION PHARMACEUTICALS LTD (CH) 2013-05-23 WO disclosed